Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Powderly

Showing results (31-40 of 128) with videos related to

Pageof 13
Sort By:
AIDS (London, England)|November 5, 1999
Nelfinavir, a new protease inhibitor: early clinical resultsW G Powderly, P Tebas
AIDS (London, England)|January 31, 2002
AIDS 2001. Clinical treatment. OverviewW G Powderly, A Carr
The AIDS Reader|May 6, 2003
Prophylaxis and treatment of opportunistic infection in patients on HAARTW Tantisiriwat, W G Powderly
Expert Opinion on Pharmacotherapy|October 5, 2001
Treatment of acute cryptococcal diseaseA Apisarnthanarak, W G Powderly
Missouri Medicine|December 1, 1991
The use of alternative therapies by HIV-positive patients attending the St. Louis AIDS Clinical Trials UnitC Rowlands, W G Powderly
The AIDS Reader|August 10, 2001
The changing face of mycoses in patients with HIV/AIDSN E Haddad, W G Powderly
Advances in Pharmacology (San Diego, Calif.)|January 1, 1997
CryptococcosisJ A Aberg, W G Powderly
AIDS Clinical Review|January 1, 1997
Cryptococcal disease: implications of recent clinical trials on treatment and managementJ A Aberg, W G Powderly
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1988
Exposure of mice to live Pseudomonas aeruginosa generates protective cell-mediated immunity in the absence of an antibody responseR B Markham, W G Powderly
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 1998
Refractory mucosal candidiasis in patients with human immunodeficiency virus infectionC J Fichtenbaum, W G Powderly
Pageof 13

Showing results (31-40 of 128) with videos related to

Sort By:
Pageof 13
AIDS (London, England)|November 5, 1999
Nelfinavir, a new protease inhibitor: early clinical resultsW G Powderly, P Tebas
AIDS (London, England)|January 31, 2002
AIDS 2001. Clinical treatment. OverviewW G Powderly, A Carr
The AIDS Reader|May 6, 2003
Prophylaxis and treatment of opportunistic infection in patients on HAARTW Tantisiriwat, W G Powderly
Expert Opinion on Pharmacotherapy|October 5, 2001
Treatment of acute cryptococcal diseaseA Apisarnthanarak, W G Powderly
Missouri Medicine|December 1, 1991
The use of alternative therapies by HIV-positive patients attending the St. Louis AIDS Clinical Trials UnitC Rowlands, W G Powderly
The AIDS Reader|August 10, 2001
The changing face of mycoses in patients with HIV/AIDSN E Haddad, W G Powderly
Advances in Pharmacology (San Diego, Calif.)|January 1, 1997
CryptococcosisJ A Aberg, W G Powderly
AIDS Clinical Review|January 1, 1997
Cryptococcal disease: implications of recent clinical trials on treatment and managementJ A Aberg, W G Powderly
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1988
Exposure of mice to live Pseudomonas aeruginosa generates protective cell-mediated immunity in the absence of an antibody responseR B Markham, W G Powderly
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 1998
Refractory mucosal candidiasis in patients with human immunodeficiency virus infectionC J Fichtenbaum, W G Powderly
Pageof 13